Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
To compare the intraocular pressure (IOP)-lowering efficacy and safety of netarsudil once daily (QD) and timolol twice daily (BID). Double-masked, randomized, phase 3, noninferiority study. Patients with open-angle glaucoma or ocular hypertension (unmedicated baseline IOP >20 to
Gespeichert in:
Veröffentlicht in: | American journal of ophthalmology 2019-08, Vol.204, p.97-104 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To compare the intraocular pressure (IOP)-lowering efficacy and safety of netarsudil once daily (QD) and timolol twice daily (BID).
Double-masked, randomized, phase 3, noninferiority study.
Patients with open-angle glaucoma or ocular hypertension (unmedicated baseline IOP >20 to |
---|---|
ISSN: | 0002-9394 1879-1891 |
DOI: | 10.1016/j.ajo.2019.03.002 |